Showing below up to 50 results in range #1 to #50.
- Institutional review board (9 categories)
- Sandbox (8 categories)
- Clinical study (7 categories)
- Investigator (7 categories)
- Legally acceptable representative (6 categories)
- Impartial witness (6 categories)
- Monitoring (6 categories)
- Protocol (6 categories)
- Independent data-monitoring committee (6 categories)
- Serious adverse event (serious adverse drug reaction) (6 categories)
- Monitoring report (6 categories)
- Unexpected adverse drug reaction (6 categories)
- Protocol Amendment (6 categories)
- Independent ethics committee (6 categories)
- Multicentre trial (6 categories)
- Quality assurance (6 categories)
- Informed consent (6 categories)
- Source documents (6 categories)
- Nonclinical study (6 categories)
- Quality control (6 categories)
- Opinion (in relation to Independent Ethics Committee) (6 categories)
- Randomization (6 categories)
- Sponsor-investigator (6 categories)
- Original medical record (6 categories)
- Interim Clinical Trial (Study) Report (6 categories)
- Regulatory authority (6 categories)
- Investigational product (6 categories)
- Sub-investigator (6 categories)
- Regulatory inspection (6 categories)
- Investigator's brochure (6 categories)
- Certified copy (5 categories)
- Trial site (5 categories)
- Clinical data management (5 categories)
- Source data (5 categories)
- Vulnerable subjects (5 categories)
- Clinical research (5 categories)
- Well-being (5 categories)
- Essential documents (5 categories)
- Institution (5 categories)
- Sponsor (5 categories)
- Standard operating procedures (5 categories)
- FDA Bioresearch monitoring (5 categories)
- Bioavailability and bioequivalence requirements (5 categories)
- Subject (5 categories)
- Subject identification code (5 categories)
- The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (4 categories)
- Corrective and Preventive Action (4 categories)
- 21 CFR 312 (4 categories)
- Comparator (4 categories)
- Audit (4 categories)